Pharma & Healthcare
Global Intravenous Human Immunoglobulin Market Insights, Forecast to 2030
- Nov 02, 24
- ID: 653306
- Pages: 110
- Figures: 134
- Views: 1
Intravenous Human Immunoglobulin
The global Intravenous Human Immunoglobulin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Intravenous Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Intravenous Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Intravenous Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Intravenous Human Immunoglobulin include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG and Shanghai RAAS, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Intravenous Human Immunoglobulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Intravenous Human Immunoglobulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intravenous Human Immunoglobulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Intravenous Human Immunoglobulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Intravenous Human Immunoglobulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Intravenous Human Immunoglobulin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Tiantan Biological(Sinopharm)
Taibang Biologic Group
Segment by Type
Liquid
Powder
Segment by Application
Hospital
Specialty Clinic
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intravenous Human Immunoglobulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Intravenous Human Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Human Immunoglobulin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Intravenous Human Immunoglobulin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Intravenous Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Intravenous Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Intravenous Human Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Intravenous Human Immunoglobulin include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG and Shanghai RAAS, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Intravenous Human Immunoglobulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Intravenous Human Immunoglobulin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Intravenous Human Immunoglobulin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Intravenous Human Immunoglobulin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Intravenous Human Immunoglobulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Intravenous Human Immunoglobulin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Tiantan Biological(Sinopharm)
Taibang Biologic Group
Segment by Type
Liquid
Powder
Segment by Application
Hospital
Specialty Clinic
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Intravenous Human Immunoglobulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Intravenous Human Immunoglobulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intravenous Human Immunoglobulin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Intravenous Human Immunoglobulin Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Human Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liquid
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Intravenous Human Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intravenous Human Immunoglobulin Sales Estimates and Forecasts 2019-2030
2.2 Global Intravenous Human Immunoglobulin Revenue by Region
2.2.1 Global Intravenous Human Immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Intravenous Human Immunoglobulin Revenue by Region (2019-2024)
2.2.3 Global Intravenous Human Immunoglobulin Revenue by Region (2025-2030)
2.2.4 Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2019-2030)
2.3 Global Intravenous Human Immunoglobulin Sales Estimates and Forecasts 2019-2030
2.4 Global Intravenous Human Immunoglobulin Sales by Region
2.4.1 Global Intravenous Human Immunoglobulin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Intravenous Human Immunoglobulin Sales by Region (2019-2024)
2.4.3 Global Intravenous Human Immunoglobulin Sales by Region (2025-2030)
2.4.4 Global Intravenous Human Immunoglobulin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intravenous Human Immunoglobulin Sales by Manufacturers
3.1.1 Global Intravenous Human Immunoglobulin Sales by Manufacturers (2019-2024)
3.1.2 Global Intravenous Human Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous Human Immunoglobulin in 2023
3.2 Global Intravenous Human Immunoglobulin Revenue by Manufacturers
3.2.1 Global Intravenous Human Immunoglobulin Revenue by Manufacturers (2019-2024)
3.2.2 Global Intravenous Human Immunoglobulin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Intravenous Human Immunoglobulin Revenue in 2023
3.3 Global Key Players of Intravenous Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Intravenous Human Immunoglobulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intravenous Human Immunoglobulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intravenous Human Immunoglobulin, Product Offered and Application
3.8 Global Key Manufacturers of Intravenous Human Immunoglobulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intravenous Human Immunoglobulin Sales by Type
4.1.1 Global Intravenous Human Immunoglobulin Historical Sales by Type (2019-2024)
4.1.2 Global Intravenous Human Immunoglobulin Forecasted Sales by Type (2025-2030)
4.1.3 Global Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Human Immunoglobulin Revenue by Type
4.2.1 Global Intravenous Human Immunoglobulin Historical Revenue by Type (2019-2024)
4.2.2 Global Intravenous Human Immunoglobulin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Human Immunoglobulin Price by Type
4.3.1 Global Intravenous Human Immunoglobulin Price by Type (2019-2024)
4.3.2 Global Intravenous Human Immunoglobulin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Intravenous Human Immunoglobulin Sales by Application
5.1.1 Global Intravenous Human Immunoglobulin Historical Sales by Application (2019-2024)
5.1.2 Global Intravenous Human Immunoglobulin Forecasted Sales by Application (2025-2030)
5.1.3 Global Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Human Immunoglobulin Revenue by Application
5.2.1 Global Intravenous Human Immunoglobulin Historical Revenue by Application (2019-2024)
5.2.2 Global Intravenous Human Immunoglobulin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Human Immunoglobulin Price by Application
5.3.1 Global Intravenous Human Immunoglobulin Price by Application (2019-2024)
5.3.2 Global Intravenous Human Immunoglobulin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Intravenous Human Immunoglobulin Market Size by Type
6.1.1 US & Canada Intravenous Human Immunoglobulin Sales by Type (2019-2030)
6.1.2 US & Canada Intravenous Human Immunoglobulin Revenue by Type (2019-2030)
6.2 US & Canada Intravenous Human Immunoglobulin Market Size by Application
6.2.1 US & Canada Intravenous Human Immunoglobulin Sales by Application (2019-2030)
6.2.2 US & Canada Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
6.3 US & Canada Intravenous Human Immunoglobulin Market Size by Country
6.3.1 US & Canada Intravenous Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Intravenous Human Immunoglobulin Sales by Country (2019-2030)
6.3.3 US & Canada Intravenous Human Immunoglobulin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intravenous Human Immunoglobulin Market Size by Type
7.1.1 Europe Intravenous Human Immunoglobulin Sales by Type (2019-2030)
7.1.2 Europe Intravenous Human Immunoglobulin Revenue by Type (2019-2030)
7.2 Europe Intravenous Human Immunoglobulin Market Size by Application
7.2.1 Europe Intravenous Human Immunoglobulin Sales by Application (2019-2030)
7.2.2 Europe Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
7.3 Europe Intravenous Human Immunoglobulin Market Size by Country
7.3.1 Europe Intravenous Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Intravenous Human Immunoglobulin Sales by Country (2019-2030)
7.3.3 Europe Intravenous Human Immunoglobulin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intravenous Human Immunoglobulin Market Size
8.1.1 China Intravenous Human Immunoglobulin Sales (2019-2030)
8.1.2 China Intravenous Human Immunoglobulin Revenue (2019-2030)
8.2 China Intravenous Human Immunoglobulin Market Size by Application
8.2.1 China Intravenous Human Immunoglobulin Sales by Application (2019-2030)
8.2.2 China Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Intravenous Human Immunoglobulin Market Size by Type
9.1.1 Asia Intravenous Human Immunoglobulin Sales by Type (2019-2030)
9.1.2 Asia Intravenous Human Immunoglobulin Revenue by Type (2019-2030)
9.2 Asia Intravenous Human Immunoglobulin Market Size by Application
9.2.1 Asia Intravenous Human Immunoglobulin Sales by Application (2019-2030)
9.2.2 Asia Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
9.3 Asia Intravenous Human Immunoglobulin Sales by Region
9.3.1 Asia Intravenous Human Immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Intravenous Human Immunoglobulin Revenue by Region (2019-2030)
9.3.3 Asia Intravenous Human Immunoglobulin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Country
10.3.1 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Information
11.1.2 Baxter Overview
11.1.3 Baxter Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Baxter Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Grifols Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 CSL Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Octapharma Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Biotest
11.5.1 Biotest Company Information
11.5.2 Biotest Overview
11.5.3 Biotest Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Biotest Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biotest Recent Developments
11.6 Kedrion
11.6.1 Kedrion Company Information
11.6.2 Kedrion Overview
11.6.3 Kedrion Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Kedrion Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kedrion Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Company Information
11.7.2 Hualan Bio Overview
11.7.3 Hualan Bio Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hualan Bio Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Bio Recent Developments
11.8 CNBG
11.8.1 CNBG Company Information
11.8.2 CNBG Overview
11.8.3 CNBG Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 CNBG Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Information
11.9.2 Shanghai RAAS Overview
11.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Shanghai RAAS Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Overview
11.10.3 CBPO Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 CBPO Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 LFB Group
11.11.1 LFB Group Company Information
11.11.2 LFB Group Overview
11.11.3 LFB Group Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 LFB Group Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 LFB Group Recent Developments
11.12 BPL
11.12.1 BPL Company Information
11.12.2 BPL Overview
11.12.3 BPL Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 BPL Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BPL Recent Developments
11.13 Tiantan Biological(Sinopharm)
11.13.1 Tiantan Biological(Sinopharm) Company Information
11.13.2 Tiantan Biological(Sinopharm) Overview
11.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Tiantan Biological(Sinopharm) Recent Developments
11.14 Taibang Biologic Group
11.14.1 Taibang Biologic Group Company Information
11.14.2 Taibang Biologic Group Overview
11.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Taibang Biologic Group Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Taibang Biologic Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intravenous Human Immunoglobulin Industry Chain Analysis
12.2 Intravenous Human Immunoglobulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravenous Human Immunoglobulin Production Mode & Process
12.4 Intravenous Human Immunoglobulin Sales and Marketing
12.4.1 Intravenous Human Immunoglobulin Sales Channels
12.4.2 Intravenous Human Immunoglobulin Distributors
12.5 Intravenous Human Immunoglobulin Customers
13 Market Dynamics
13.1 Intravenous Human Immunoglobulin Industry Trends
13.2 Intravenous Human Immunoglobulin Market Drivers
13.3 Intravenous Human Immunoglobulin Market Challenges
13.4 Intravenous Human Immunoglobulin Market Restraints
14 Key Findings in The Global Intravenous Human Immunoglobulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Intravenous Human Immunoglobulin Product Introduction
1.2 Market by Type
1.2.1 Global Intravenous Human Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liquid
1.2.3 Powder
1.3 Market by Application
1.3.1 Global Intravenous Human Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Intravenous Human Immunoglobulin Sales Estimates and Forecasts 2019-2030
2.2 Global Intravenous Human Immunoglobulin Revenue by Region
2.2.1 Global Intravenous Human Immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Intravenous Human Immunoglobulin Revenue by Region (2019-2024)
2.2.3 Global Intravenous Human Immunoglobulin Revenue by Region (2025-2030)
2.2.4 Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2019-2030)
2.3 Global Intravenous Human Immunoglobulin Sales Estimates and Forecasts 2019-2030
2.4 Global Intravenous Human Immunoglobulin Sales by Region
2.4.1 Global Intravenous Human Immunoglobulin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Intravenous Human Immunoglobulin Sales by Region (2019-2024)
2.4.3 Global Intravenous Human Immunoglobulin Sales by Region (2025-2030)
2.4.4 Global Intravenous Human Immunoglobulin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Intravenous Human Immunoglobulin Sales by Manufacturers
3.1.1 Global Intravenous Human Immunoglobulin Sales by Manufacturers (2019-2024)
3.1.2 Global Intravenous Human Immunoglobulin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Intravenous Human Immunoglobulin in 2023
3.2 Global Intravenous Human Immunoglobulin Revenue by Manufacturers
3.2.1 Global Intravenous Human Immunoglobulin Revenue by Manufacturers (2019-2024)
3.2.2 Global Intravenous Human Immunoglobulin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Intravenous Human Immunoglobulin Revenue in 2023
3.3 Global Key Players of Intravenous Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Intravenous Human Immunoglobulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Intravenous Human Immunoglobulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Intravenous Human Immunoglobulin, Product Offered and Application
3.8 Global Key Manufacturers of Intravenous Human Immunoglobulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intravenous Human Immunoglobulin Sales by Type
4.1.1 Global Intravenous Human Immunoglobulin Historical Sales by Type (2019-2024)
4.1.2 Global Intravenous Human Immunoglobulin Forecasted Sales by Type (2025-2030)
4.1.3 Global Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
4.2 Global Intravenous Human Immunoglobulin Revenue by Type
4.2.1 Global Intravenous Human Immunoglobulin Historical Revenue by Type (2019-2024)
4.2.2 Global Intravenous Human Immunoglobulin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
4.3 Global Intravenous Human Immunoglobulin Price by Type
4.3.1 Global Intravenous Human Immunoglobulin Price by Type (2019-2024)
4.3.2 Global Intravenous Human Immunoglobulin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Intravenous Human Immunoglobulin Sales by Application
5.1.1 Global Intravenous Human Immunoglobulin Historical Sales by Application (2019-2024)
5.1.2 Global Intravenous Human Immunoglobulin Forecasted Sales by Application (2025-2030)
5.1.3 Global Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
5.2 Global Intravenous Human Immunoglobulin Revenue by Application
5.2.1 Global Intravenous Human Immunoglobulin Historical Revenue by Application (2019-2024)
5.2.2 Global Intravenous Human Immunoglobulin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
5.3 Global Intravenous Human Immunoglobulin Price by Application
5.3.1 Global Intravenous Human Immunoglobulin Price by Application (2019-2024)
5.3.2 Global Intravenous Human Immunoglobulin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Intravenous Human Immunoglobulin Market Size by Type
6.1.1 US & Canada Intravenous Human Immunoglobulin Sales by Type (2019-2030)
6.1.2 US & Canada Intravenous Human Immunoglobulin Revenue by Type (2019-2030)
6.2 US & Canada Intravenous Human Immunoglobulin Market Size by Application
6.2.1 US & Canada Intravenous Human Immunoglobulin Sales by Application (2019-2030)
6.2.2 US & Canada Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
6.3 US & Canada Intravenous Human Immunoglobulin Market Size by Country
6.3.1 US & Canada Intravenous Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Intravenous Human Immunoglobulin Sales by Country (2019-2030)
6.3.3 US & Canada Intravenous Human Immunoglobulin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Intravenous Human Immunoglobulin Market Size by Type
7.1.1 Europe Intravenous Human Immunoglobulin Sales by Type (2019-2030)
7.1.2 Europe Intravenous Human Immunoglobulin Revenue by Type (2019-2030)
7.2 Europe Intravenous Human Immunoglobulin Market Size by Application
7.2.1 Europe Intravenous Human Immunoglobulin Sales by Application (2019-2030)
7.2.2 Europe Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
7.3 Europe Intravenous Human Immunoglobulin Market Size by Country
7.3.1 Europe Intravenous Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Intravenous Human Immunoglobulin Sales by Country (2019-2030)
7.3.3 Europe Intravenous Human Immunoglobulin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Intravenous Human Immunoglobulin Market Size
8.1.1 China Intravenous Human Immunoglobulin Sales (2019-2030)
8.1.2 China Intravenous Human Immunoglobulin Revenue (2019-2030)
8.2 China Intravenous Human Immunoglobulin Market Size by Application
8.2.1 China Intravenous Human Immunoglobulin Sales by Application (2019-2030)
8.2.2 China Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Intravenous Human Immunoglobulin Market Size by Type
9.1.1 Asia Intravenous Human Immunoglobulin Sales by Type (2019-2030)
9.1.2 Asia Intravenous Human Immunoglobulin Revenue by Type (2019-2030)
9.2 Asia Intravenous Human Immunoglobulin Market Size by Application
9.2.1 Asia Intravenous Human Immunoglobulin Sales by Application (2019-2030)
9.2.2 Asia Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
9.3 Asia Intravenous Human Immunoglobulin Sales by Region
9.3.1 Asia Intravenous Human Immunoglobulin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Intravenous Human Immunoglobulin Revenue by Region (2019-2030)
9.3.3 Asia Intravenous Human Immunoglobulin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Country
10.3.1 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Information
11.1.2 Baxter Overview
11.1.3 Baxter Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Baxter Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Grifols Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 CSL Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Octapharma Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Biotest
11.5.1 Biotest Company Information
11.5.2 Biotest Overview
11.5.3 Biotest Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Biotest Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biotest Recent Developments
11.6 Kedrion
11.6.1 Kedrion Company Information
11.6.2 Kedrion Overview
11.6.3 Kedrion Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Kedrion Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kedrion Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Company Information
11.7.2 Hualan Bio Overview
11.7.3 Hualan Bio Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hualan Bio Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Bio Recent Developments
11.8 CNBG
11.8.1 CNBG Company Information
11.8.2 CNBG Overview
11.8.3 CNBG Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 CNBG Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 Shanghai RAAS
11.9.1 Shanghai RAAS Company Information
11.9.2 Shanghai RAAS Overview
11.9.3 Shanghai RAAS Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Shanghai RAAS Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Overview
11.10.3 CBPO Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 CBPO Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 LFB Group
11.11.1 LFB Group Company Information
11.11.2 LFB Group Overview
11.11.3 LFB Group Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 LFB Group Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 LFB Group Recent Developments
11.12 BPL
11.12.1 BPL Company Information
11.12.2 BPL Overview
11.12.3 BPL Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 BPL Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BPL Recent Developments
11.13 Tiantan Biological(Sinopharm)
11.13.1 Tiantan Biological(Sinopharm) Company Information
11.13.2 Tiantan Biological(Sinopharm) Overview
11.13.3 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Tiantan Biological(Sinopharm) Recent Developments
11.14 Taibang Biologic Group
11.14.1 Taibang Biologic Group Company Information
11.14.2 Taibang Biologic Group Overview
11.14.3 Taibang Biologic Group Intravenous Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Taibang Biologic Group Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Taibang Biologic Group Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Intravenous Human Immunoglobulin Industry Chain Analysis
12.2 Intravenous Human Immunoglobulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Intravenous Human Immunoglobulin Production Mode & Process
12.4 Intravenous Human Immunoglobulin Sales and Marketing
12.4.1 Intravenous Human Immunoglobulin Sales Channels
12.4.2 Intravenous Human Immunoglobulin Distributors
12.5 Intravenous Human Immunoglobulin Customers
13 Market Dynamics
13.1 Intravenous Human Immunoglobulin Industry Trends
13.2 Intravenous Human Immunoglobulin Market Drivers
13.3 Intravenous Human Immunoglobulin Market Challenges
13.4 Intravenous Human Immunoglobulin Market Restraints
14 Key Findings in The Global Intravenous Human Immunoglobulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Intravenous Human Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Liquid
Table 3. Major Manufacturers of Powder
Table 4. Global Intravenous Human Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Intravenous Human Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Intravenous Human Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2019-2024)
Table 9. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2025-2030)
Table 10. Global Intravenous Human Immunoglobulin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Intravenous Human Immunoglobulin Sales by Region (2019-2024) & (K Units)
Table 12. Global Intravenous Human Immunoglobulin Sales by Region (2025-2030) & (K Units)
Table 13. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2019-2024)
Table 14. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2025-2030)
Table 15. Global Intravenous Human Immunoglobulin Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Intravenous Human Immunoglobulin Sales Share by Manufacturers (2019-2024)
Table 17. Global Intravenous Human Immunoglobulin Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Intravenous Human Immunoglobulin Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Intravenous Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Intravenous Human Immunoglobulin Price by Manufacturers 2019-2024 (USD/Unit)
Table 21. Global Intravenous Human Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Intravenous Human Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Human Immunoglobulin as of 2023)
Table 23. Global Key Manufacturers of Intravenous Human Immunoglobulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Intravenous Human Immunoglobulin, Product Offered and Application
Table 25. Global Key Manufacturers of Intravenous Human Immunoglobulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 28. Global Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 29. Global Intravenous Human Immunoglobulin Sales Share by Type (2019-2024)
Table 30. Global Intravenous Human Immunoglobulin Sales Share by Type (2025-2030)
Table 31. Global Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Intravenous Human Immunoglobulin Revenue Share by Type (2019-2024)
Table 34. Global Intravenous Human Immunoglobulin Revenue Share by Type (2025-2030)
Table 35. Intravenous Human Immunoglobulin Price by Type (2019-2024) & (USD/Unit)
Table 36. Global Intravenous Human Immunoglobulin Price Forecast by Type (2025-2030) & (USD/Unit)
Table 37. Global Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 38. Global Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 39. Global Intravenous Human Immunoglobulin Sales Share by Application (2019-2024)
Table 40. Global Intravenous Human Immunoglobulin Sales Share by Application (2025-2030)
Table 41. Global Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Intravenous Human Immunoglobulin Revenue Share by Application (2019-2024)
Table 44. Global Intravenous Human Immunoglobulin Revenue Share by Application (2025-2030)
Table 45. Intravenous Human Immunoglobulin Price by Application (2019-2024) & (USD/Unit)
Table 46. Global Intravenous Human Immunoglobulin Price Forecast by Application (2025-2030) & (USD/Unit)
Table 47. US & Canada Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Intravenous Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Intravenous Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Intravenous Human Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Intravenous Human Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 60. Europe Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 61. Europe Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 62. Europe Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 65. Europe Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 66. Europe Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Intravenous Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Intravenous Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Intravenous Human Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 72. Europe Intravenous Human Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 73. China Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 74. China Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 75. China Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 78. China Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 79. China Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 82. Asia Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 83. Asia Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 86. Asia Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 87. Asia Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Intravenous Human Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Intravenous Human Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Intravenous Human Immunoglobulin Sales by Region (2019-2024) & (K Units)
Table 93. Asia Intravenous Human Immunoglobulin Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 107. Baxter Company Information
Table 108. Baxter Description and Major Businesses
Table 109. Baxter Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Baxter Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Baxter Recent Developments
Table 112. Grifols Company Information
Table 113. Grifols Description and Major Businesses
Table 114. Grifols Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Grifols Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Grifols Recent Developments
Table 117. CSL Company Information
Table 118. CSL Description and Major Businesses
Table 119. CSL Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. CSL Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. CSL Recent Developments
Table 122. Octapharma Company Information
Table 123. Octapharma Description and Major Businesses
Table 124. Octapharma Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Octapharma Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Octapharma Recent Developments
Table 127. Biotest Company Information
Table 128. Biotest Description and Major Businesses
Table 129. Biotest Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Biotest Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Biotest Recent Developments
Table 132. Kedrion Company Information
Table 133. Kedrion Description and Major Businesses
Table 134. Kedrion Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Kedrion Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Kedrion Recent Developments
Table 137. Hualan Bio Company Information
Table 138. Hualan Bio Description and Major Businesses
Table 139. Hualan Bio Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Hualan Bio Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hualan Bio Recent Developments
Table 142. CNBG Company Information
Table 143. CNBG Description and Major Businesses
Table 144. CNBG Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. CNBG Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. CNBG Recent Developments
Table 147. Shanghai RAAS Company Information
Table 148. Shanghai RAAS Description and Major Businesses
Table 149. Shanghai RAAS Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Shanghai RAAS Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Shanghai RAAS Recent Developments
Table 152. CBPO Company Information
Table 153. CBPO Description and Major Businesses
Table 154. CBPO Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. CBPO Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CBPO Recent Developments
Table 157. LFB Group Company Information
Table 158. LFB Group Description and Major Businesses
Table 159. LFB Group Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 160. LFB Group Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. LFB Group Recent Developments
Table 162. BPL Company Information
Table 163. BPL Description and Major Businesses
Table 164. BPL Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 165. BPL Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. BPL Recent Developments
Table 167. Tiantan Biological(Sinopharm) Company Information
Table 168. Tiantan Biological(Sinopharm) Description and Major Businesses
Table 169. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 170. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Tiantan Biological(Sinopharm) Recent Developments
Table 172. Taibang Biologic Group Company Information
Table 173. Taibang Biologic Group Description and Major Businesses
Table 174. Taibang Biologic Group Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 175. Taibang Biologic Group Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Taibang Biologic Group Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Intravenous Human Immunoglobulin Distributors List
Table 180. Intravenous Human Immunoglobulin Customers List
Table 181. Intravenous Human Immunoglobulin Market Trends
Table 182. Intravenous Human Immunoglobulin Market Drivers
Table 183. Intravenous Human Immunoglobulin Market Challenges
Table 184. Intravenous Human Immunoglobulin Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Human Immunoglobulin Product Picture
Figure 2. Global Intravenous Human Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Intravenous Human Immunoglobulin Market Share by Type in 2023 & 2030
Figure 4. Liquid Product Picture
Figure 5. Powder Product Picture
Figure 6. Global Intravenous Human Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Intravenous Human Immunoglobulin Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Specialty Clinic
Figure 10. Others
Figure 11. Intravenous Human Immunoglobulin Report Years Considered
Figure 12. Global Intravenous Human Immunoglobulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Intravenous Human Immunoglobulin Revenue 2019-2030 (US$ Million)
Figure 14. Global Intravenous Human Immunoglobulin Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2019-2030)
Figure 16. Global Intravenous Human Immunoglobulin Sales 2019-2030 ((K Units)
Figure 17. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 19. US & Canada Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 23. China Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 25. Asia (excluding China) Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 27. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Intravenous Human Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Intravenous Human Immunoglobulin in the World: Market Share by Intravenous Human Immunoglobulin Revenue in 2023
Figure 30. Global Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 32. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 33. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 34. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Intravenous Human Immunoglobulin Revenue Share by Country (2019-2030)
Figure 40. US & Canada Intravenous Human Immunoglobulin Sales Share by Country (2019-2030)
Figure 41. U.S. Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 44. Europe Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 45. Europe Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 46. Europe Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 47. Europe Intravenous Human Immunoglobulin Revenue Share by Country (2019-2030)
Figure 48. Europe Intravenous Human Immunoglobulin Sales Share by Country (2019-2030)
Figure 49. Germany Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 50. France Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 54. China Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 55. China Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 56. China Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 57. China Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 58. Asia Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 59. Asia Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 60. Asia Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 61. Asia Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 62. Asia Intravenous Human Immunoglobulin Revenue Share by Region (2019-2030)
Figure 63. Asia Intravenous Human Immunoglobulin Sales Share by Region (2019-2030)
Figure 64. Japan Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 68. India Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales Share by Country (2019-2030)
Figure 75. Brazil Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 80. Intravenous Human Immunoglobulin Value Chain
Figure 81. Intravenous Human Immunoglobulin Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Table 1. Global Intravenous Human Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Liquid
Table 3. Major Manufacturers of Powder
Table 4. Global Intravenous Human Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Intravenous Human Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Intravenous Human Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2019-2024)
Table 9. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2025-2030)
Table 10. Global Intravenous Human Immunoglobulin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Intravenous Human Immunoglobulin Sales by Region (2019-2024) & (K Units)
Table 12. Global Intravenous Human Immunoglobulin Sales by Region (2025-2030) & (K Units)
Table 13. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2019-2024)
Table 14. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2025-2030)
Table 15. Global Intravenous Human Immunoglobulin Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Intravenous Human Immunoglobulin Sales Share by Manufacturers (2019-2024)
Table 17. Global Intravenous Human Immunoglobulin Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Intravenous Human Immunoglobulin Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Intravenous Human Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Intravenous Human Immunoglobulin Price by Manufacturers 2019-2024 (USD/Unit)
Table 21. Global Intravenous Human Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Intravenous Human Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Human Immunoglobulin as of 2023)
Table 23. Global Key Manufacturers of Intravenous Human Immunoglobulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Intravenous Human Immunoglobulin, Product Offered and Application
Table 25. Global Key Manufacturers of Intravenous Human Immunoglobulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 28. Global Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 29. Global Intravenous Human Immunoglobulin Sales Share by Type (2019-2024)
Table 30. Global Intravenous Human Immunoglobulin Sales Share by Type (2025-2030)
Table 31. Global Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Intravenous Human Immunoglobulin Revenue Share by Type (2019-2024)
Table 34. Global Intravenous Human Immunoglobulin Revenue Share by Type (2025-2030)
Table 35. Intravenous Human Immunoglobulin Price by Type (2019-2024) & (USD/Unit)
Table 36. Global Intravenous Human Immunoglobulin Price Forecast by Type (2025-2030) & (USD/Unit)
Table 37. Global Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 38. Global Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 39. Global Intravenous Human Immunoglobulin Sales Share by Application (2019-2024)
Table 40. Global Intravenous Human Immunoglobulin Sales Share by Application (2025-2030)
Table 41. Global Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Intravenous Human Immunoglobulin Revenue Share by Application (2019-2024)
Table 44. Global Intravenous Human Immunoglobulin Revenue Share by Application (2025-2030)
Table 45. Intravenous Human Immunoglobulin Price by Application (2019-2024) & (USD/Unit)
Table 46. Global Intravenous Human Immunoglobulin Price Forecast by Application (2025-2030) & (USD/Unit)
Table 47. US & Canada Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Intravenous Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Intravenous Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Intravenous Human Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Intravenous Human Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 60. Europe Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 61. Europe Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 62. Europe Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 65. Europe Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 66. Europe Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Intravenous Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Intravenous Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Intravenous Human Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 72. Europe Intravenous Human Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 73. China Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 74. China Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 75. China Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 78. China Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 79. China Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 82. Asia Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 83. Asia Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 86. Asia Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 87. Asia Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Intravenous Human Immunoglobulin Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Intravenous Human Immunoglobulin Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Intravenous Human Immunoglobulin Sales by Region (2019-2024) & (K Units)
Table 93. Asia Intravenous Human Immunoglobulin Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales by Country (2025-2030) & (K Units)
Table 107. Baxter Company Information
Table 108. Baxter Description and Major Businesses
Table 109. Baxter Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. Baxter Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Baxter Recent Developments
Table 112. Grifols Company Information
Table 113. Grifols Description and Major Businesses
Table 114. Grifols Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Grifols Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Grifols Recent Developments
Table 117. CSL Company Information
Table 118. CSL Description and Major Businesses
Table 119. CSL Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. CSL Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. CSL Recent Developments
Table 122. Octapharma Company Information
Table 123. Octapharma Description and Major Businesses
Table 124. Octapharma Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 125. Octapharma Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Octapharma Recent Developments
Table 127. Biotest Company Information
Table 128. Biotest Description and Major Businesses
Table 129. Biotest Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 130. Biotest Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Biotest Recent Developments
Table 132. Kedrion Company Information
Table 133. Kedrion Description and Major Businesses
Table 134. Kedrion Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 135. Kedrion Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Kedrion Recent Developments
Table 137. Hualan Bio Company Information
Table 138. Hualan Bio Description and Major Businesses
Table 139. Hualan Bio Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 140. Hualan Bio Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hualan Bio Recent Developments
Table 142. CNBG Company Information
Table 143. CNBG Description and Major Businesses
Table 144. CNBG Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 145. CNBG Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. CNBG Recent Developments
Table 147. Shanghai RAAS Company Information
Table 148. Shanghai RAAS Description and Major Businesses
Table 149. Shanghai RAAS Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 150. Shanghai RAAS Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Shanghai RAAS Recent Developments
Table 152. CBPO Company Information
Table 153. CBPO Description and Major Businesses
Table 154. CBPO Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 155. CBPO Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CBPO Recent Developments
Table 157. LFB Group Company Information
Table 158. LFB Group Description and Major Businesses
Table 159. LFB Group Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 160. LFB Group Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. LFB Group Recent Developments
Table 162. BPL Company Information
Table 163. BPL Description and Major Businesses
Table 164. BPL Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 165. BPL Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. BPL Recent Developments
Table 167. Tiantan Biological(Sinopharm) Company Information
Table 168. Tiantan Biological(Sinopharm) Description and Major Businesses
Table 169. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 170. Tiantan Biological(Sinopharm) Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Tiantan Biological(Sinopharm) Recent Developments
Table 172. Taibang Biologic Group Company Information
Table 173. Taibang Biologic Group Description and Major Businesses
Table 174. Taibang Biologic Group Intravenous Human Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 175. Taibang Biologic Group Intravenous Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Taibang Biologic Group Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Intravenous Human Immunoglobulin Distributors List
Table 180. Intravenous Human Immunoglobulin Customers List
Table 181. Intravenous Human Immunoglobulin Market Trends
Table 182. Intravenous Human Immunoglobulin Market Drivers
Table 183. Intravenous Human Immunoglobulin Market Challenges
Table 184. Intravenous Human Immunoglobulin Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Human Immunoglobulin Product Picture
Figure 2. Global Intravenous Human Immunoglobulin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Intravenous Human Immunoglobulin Market Share by Type in 2023 & 2030
Figure 4. Liquid Product Picture
Figure 5. Powder Product Picture
Figure 6. Global Intravenous Human Immunoglobulin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Intravenous Human Immunoglobulin Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Specialty Clinic
Figure 10. Others
Figure 11. Intravenous Human Immunoglobulin Report Years Considered
Figure 12. Global Intravenous Human Immunoglobulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Intravenous Human Immunoglobulin Revenue 2019-2030 (US$ Million)
Figure 14. Global Intravenous Human Immunoglobulin Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Intravenous Human Immunoglobulin Revenue Market Share by Region (2019-2030)
Figure 16. Global Intravenous Human Immunoglobulin Sales 2019-2030 ((K Units)
Figure 17. Global Intravenous Human Immunoglobulin Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 19. US & Canada Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 21. Europe Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 23. China Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 24. Asia (excluding China) Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 25. Asia (excluding China) Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales YoY (2019-2030) & (K Units)
Figure 27. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Intravenous Human Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 29. The Top 5 and 10 Largest Manufacturers of Intravenous Human Immunoglobulin in the World: Market Share by Intravenous Human Immunoglobulin Revenue in 2023
Figure 30. Global Intravenous Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 32. Global Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 33. Global Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 34. Global Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 35. US & Canada Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 36. US & Canada Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 37. US & Canada Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 38. US & Canada Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 39. US & Canada Intravenous Human Immunoglobulin Revenue Share by Country (2019-2030)
Figure 40. US & Canada Intravenous Human Immunoglobulin Sales Share by Country (2019-2030)
Figure 41. U.S. Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 42. Canada Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 43. Europe Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 44. Europe Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 45. Europe Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 46. Europe Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 47. Europe Intravenous Human Immunoglobulin Revenue Share by Country (2019-2030)
Figure 48. Europe Intravenous Human Immunoglobulin Sales Share by Country (2019-2030)
Figure 49. Germany Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 50. France Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 51. U.K. Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 52. Italy Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 53. Russia Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 54. China Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 55. China Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 56. China Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 57. China Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 58. Asia Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 59. Asia Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 60. Asia Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 61. Asia Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 62. Asia Intravenous Human Immunoglobulin Revenue Share by Region (2019-2030)
Figure 63. Asia Intravenous Human Immunoglobulin Sales Share by Region (2019-2030)
Figure 64. Japan Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 68. India Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America Intravenous Human Immunoglobulin Sales Share by Country (2019-2030)
Figure 75. Brazil Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 78. Israel Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries Intravenous Human Immunoglobulin Revenue (2019-2030) & (US$ Million)
Figure 80. Intravenous Human Immunoglobulin Value Chain
Figure 81. Intravenous Human Immunoglobulin Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232